STENT
POSITIONING
ASSISTANCE
SYSTEM
SPAS® introduces a new standard of care in Coronary Stenting bringing it to the next level of safety and efficiency.
NEXT LEVEL OF SAFETY
IN CORONARY STENTING
Current stenting devices are user-dependent and require strong skills in complex pathologies, such as bifurcation lesions of the coronary artery, ostial and bifurcational lesions, stenting in ongoing myocardial infraction, and edge-to-edge positioning. SPAS® allows for significantly reduced time-to-placement in any stenting procedure including complicated coronary conditions and acute myocardial infarction where time-to-stenting is crucial. SPAS® is expected to allow for higher surgery success rates, shorter hospitalization and overall decreased care costs.
HIGHEST LEVEL
OF PROFESSIONAL
CONFIDENCE
SPAS® is user independent. It eliminates possible surgeon’s hand tremor, allows for stronger confidence for less experienced interventional cardiologists. It is expected to minimize risks of misplacements, deployment of additional stents and other complications occurring due to imprecise placement. SPAS® allows for better experience for both patients and cardiologists. It reduces risks of misplacement and perforation, requires less fluoroscopy and minimizes radiation exposure.
About SPAS®
DESCRIPTION
SPAS® is a mechanical torque-like device which allows for precise stent placement by easy one-handed manipulation, with an option of back and forward movement for repositioning. SPAS® seamlessly complements any stent delivery system, becoming an “extension” of the surgeon's hand making it precisely accurate.
OPERATING PRINCIPLE
SPAS® represents the ultimate solution for safe and precise stent positioning. This unique accessory allows for a stent placement precision at a fraction of a 0.5mm. With the SPAS device in place, precise positioning of the stent at the target lesion site is achieves by simple one-handed mechanical rotation. Turning the rotating handle will move the delivery system by several millimetres or by a fraction of millimetre depending on the need.
DESIGN
SPAS® is made of cast medical polymers. It is compatible with coronary stent delivery systems of all major manufacturers and designed for single-use.
SPAS® | Advantages
1
INNOVATION
IN CORONARY STENTING
We currently see that completely biodegradable / bioresorptive scaffolds dissolving in arteries within two or more years post-installation are being more and more extensively used. One of the surgical issues when they are placed is poor imaging quality that makes positioning and implantation process for these stents even more challenging. This problem can be resolved by adopting SPAS devices in routine clinical practice.
2
REDUCED CORONARY
STENTING COSTS
Virtually all the SPAS advantages currently apparent, namely shorter surgery time, less contrast media consumption, and fewer repeated interventions expected, result in lower coronary surgery costs. And that is something in which patients, hospital management and medical insurance companies are directly.
1
SPAS® — INNOVATION IN CORONARY STENTING
We currently see that completely biodegradable / bioresorptive scaffolds dissolving in arteries within two or more years post-installation are being more and more extensively used. One of the surgical issues when they are placed is poor imaging quality that makes positioning and implantation process for these stents even more challenging. This problem can be resolved by adopting SPAS devices in routine clinical practice.
2
SPAS® — REDUCED CORONARY STENTING COSTS
Virtually all the SPAS® advantages currently apparent, namely shorter surgery time, less contrast media consumption, and fewer repeated interventions expected, result in lower coronary surgery costs. And that is something in which patients, hospital management and medical insurance companies are directly.
SPAS® | Management Team
Marc van der PlasCEO
Serial entrepreneur in the medical device field, investor in early stage and growth companies with a focus on the healthcare sector. Former KPMG Corporate Finance Partner & Board Member.
Gerard WinkelsChief Strategy, Business Development
Former VP Business Lead Image Guided Therapy BI with Philips,
Board member of Corindus, acquired by Phillips.
Inna MartinCOO & CFO
Former Partner at $760 M venture project established between a sovereign fund and Domain Associates LLC, a leading US healthcare VC. Board Member at ReVision Optics Inc., Ocunexus Inc., Ocon Medical Ltd., IR-Med Ltd. and Revium Recovery Inc.
Jeroen KortsmitClinical Affairs, Product Management
PhD in Biomedical Engineering with extensive experience in Medical Devices in both business and R&D, unique scientific competences. Extensive clinical and marketing experience.
Marc van der Plas
(CEO)
Serial entrepreneur in the medical device field, investor in early stage and growth companies with a focus on the healthcare sector. Former KPMG Corporate Finance Partner & Board Member.
Gerard Winkels
(Chief Strategy, Business Development)
Former VP Business Lead Image Guided Therapy BI with Philips,
Board member of Corindus, acquired by Phillips.
Inna Martin
(Chief Finance, Operations Officer)
Former Partner at $760 M venture project established between a sovereign fund and Domain Associates LLC, a leading US healthcare VC. Board Member at ReVision Optics Inc., Ocunexus Inc., Ocon Medical Ltd., IR-Med Ltd. and Revium Recovery Inc.
Jeroen Kortsmit
(Clinical Affairs, Product Management)
PhD in Biomedical Engineering with extensive experience in Medical Devices in both business and R&D, unique scientific competences. Extensive clinical and marketing experience.
